These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 11825298)

  • 21. Systematic review and meta-analysis of combination therapy for smoking cessation.
    Shah SD; Wilken LA; Winkler SR; Lin SJ
    J Am Pharm Assoc (2003); 2008; 48(5):659-65. PubMed ID: 18826906
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Non-nicotine pharmacotherapy for smoking cessation.
    Ferry LH
    Prim Care; 1999 Sep; 26(3):653-69. PubMed ID: 10436292
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Interventions for smoking cessation and reduction in individuals with schizophrenia.
    Tsoi DT; Porwal M; Webster AC
    Cochrane Database Syst Rev; 2010 Jun; (6):CD007253. PubMed ID: 20556777
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Bupropion for the treatment of tobacco dependence: guidelines for balancing risks and benefits.
    Hays JT; Ebbert JO
    CNS Drugs; 2003; 17(2):71-83. PubMed ID: 12521356
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The relevance and treatment of cue-induced cravings in tobacco dependence.
    Ferguson SG; Shiffman S
    J Subst Abuse Treat; 2009 Apr; 36(3):235-43. PubMed ID: 18715743
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Nicotine replacement therapy for smoking cessation.
    Silagy C; Mant D; Fowler G; Lancaster T
    Cochrane Database Syst Rev; 2000; (2):CD000146. PubMed ID: 10796494
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pharmacotherapy for treating tobacco dependence: what is the ideal duration of therapy?
    Sims TH; Fiore MC
    CNS Drugs; 2002; 16(10):653-62. PubMed ID: 12269859
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pharmacologic interventions for smoking cessation.
    Corelli RL; Hudmon KS
    Crit Care Nurs Clin North Am; 2006 Mar; 18(1):39-51, xii. PubMed ID: 16546007
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The role of pharmacotherapy in assisting smoking cessation.
    Waring WS
    Eur J Clin Pharmacol; 2003 Sep; 59(5-6):351-6. PubMed ID: 12898083
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Pharmacotherapy of smoking cessation with application of nicotine and nicotine free drugs].
    Florek E; Piekoszewski W
    Przegl Lek; 2008; 65(10):700-5. PubMed ID: 19189582
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Role of nicotine pharmacokinetics in nicotine addiction and nicotine replacement therapy: a review.
    Le Houezec J
    Int J Tuberc Lung Dis; 2003 Sep; 7(9):811-9. PubMed ID: 12971663
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Current and future medical drugs for smoking cessation].
    Kusma B; Mache S; Deissenrieder F; Quarcoo D; Welte T; Groneberg D
    Laryngorhinootologie; 2009 Jun; 88(6):410-9; quiz 420-2. PubMed ID: 19504411
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Drugs for tobacco dependence.
    Treat Guidel Med Lett; 2008 Sep; 6(73):61-6. PubMed ID: 18719526
    [No Abstract]   [Full Text] [Related]  

  • 34. Cost-effectiveness analysis of the first-line therapies for nicotine dependence.
    Cornuz J; Pinget C; Gilbert A; Paccaud F
    Eur J Clin Pharmacol; 2003 Jul; 59(3):201-6. PubMed ID: 12759795
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pharmacotherapy for nicotine dependence.
    Henningfield JE; Fant RV; Buchhalter AR; Stitzer ML
    CA Cancer J Clin; 2005; 55(5):281-99; quiz 322-3, 325. PubMed ID: 16166074
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Treatment of nicotine addiction. Drug therapy for smoking cessation].
    Pedersen ST; Christensen HR; Døssing M
    Ugeskr Laeger; 2002 Mar; 164(11):1480-4. PubMed ID: 11924470
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Smoking cessation.
    Marlow SP; Stoller JK
    Respir Care; 2003 Dec; 48(12):1238-54; discussion 1254-6. PubMed ID: 14651764
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A 12-week double-blind, placebo-controlled study of bupropion sr added to high-dose dual nicotine replacement therapy for smoking cessation or reduction in schizophrenia.
    Evins AE; Cather C; Culhane MA; Birnbaum A; Horowitz J; Hsieh E; Freudenreich O; Henderson DC; Schoenfeld DA; Rigotti NA; Goff DC
    J Clin Psychopharmacol; 2007 Aug; 27(4):380-6. PubMed ID: 17632223
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pharmacotherapy for smoking cessation: present and future.
    Aubin HJ; Karila L; Reynaud M
    Curr Pharm Des; 2011; 17(14):1343-50. PubMed ID: 21524268
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Design considerations for a study to evaluate the impact of smoking cessation treatment on stimulant use outcomes in stimulant-dependent individuals.
    Winhusen T; Stitzer M; Woody G; Brigham G; Kropp F; Ghitza U; Lindblad R; Adinoff B; Green C; Sharma G; Somoza E
    Contemp Clin Trials; 2012 Jan; 33(1):197-205. PubMed ID: 22005174
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.